Skip to content

Multi-center clinical research of point-of-care (POCT) fully automatic new coronavirus diagnostic system and kit based on microfluidic magneto-sensitive chip

Multi-center clinical research of point-of-care (POCT) fully automatic new coronavirus diagnostic system and kit based on microfluidic magneto-sensitive chip

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049232
Enrollment
Unknown
Registered
2021-07-27
Start date
2021-08-09
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:The antibody titers of blood samples were detected by WANTAI electrochemiluminescence assay
quantitative&#32
detection&#32
technology&#32
based&#32
on&#32
fluidic&#32
magnetosensitive&#32
biochip&#32
the&#32
of&#32
rapid,&#32
closed,&#32

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 18-60 years old; 2. Intensive medicine doctors, nurses and respiratory therapists; 3. Inoculated or not vaccinated against the new crown inactivated vaccine; 4. Sign the informed consent; 5. Patients who have recovered from the new crown infection.

Exclusion criteria

Exclusion criteria: 1. Pregnant patients; 2. Acute skin lesions are associated with COVID-19.

Design outcomes

Primary

MeasureTime frame
Blood novel coronavirus total antibody and neutralizing antibody;

Secondary

MeasureTime frame
Coronavirus incidence;

Countries

China

Contacts

Public ContactKang Yan

West China Hospital of Sichuan University

kangyan@scu.edu.cn+86 18980601566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026